The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ZUMA-4: A phase 1/2 multicenter study evaluating the safety and efficacy of KTE-C19 (anti-CD19 CAR T cells) in pediatric and adolescent subjects with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL).
 
Alan S. Wayne
Honoraria - Kite, a Gilead company; MedImmune; Pfizer; Spectrum Pharmaceuticals
Consulting or Advisory Role - Pfizer
 
Leonard S. Sender
No Relationships to Disclose
 
Daniel Warnell Lee
No Relationships to Disclose
 
Rupert Handgretinger
No Relationships to Disclose
 
Patrick A. Brown
No Relationships to Disclose
 
Yizhou Jiang
Stock and Other Ownership Interests - Kite, a Gilead company
 
Lynn Navale
Employment - Kite, a Gilead company
 
Shanna Stout
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Amgen; Kite, a Gilead company
 
Jeff Aycock
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Jeffrey S. Wiezorek
Employment - Kite, a Gilead company
Leadership - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
Rajul K. Jain
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company